The global exoskeleton market size was estimated at USD 498.33 million in 2024 and is projected to grow at a CAGR of 16.27% from 2025 to 2030. Rapidly growing global geriatric population, rising adoption rates of medical devices in different industries such as automobile, military, defense, and construction, and rising incidence of stroke are some of the key driving forces responsible for the exoskeleton market growth. Furthermore, the growing incidence rate of spinal cord injuries (SCI) is expected to drive the demand across global markets. For instance, as per the National Spinal Cord Injury Statistical Center (NSCISC), in the U.S., 17,730 new SCIs are diagnosed annually, and approximately 291,000 live with SCIs .
Exoskeleton solutions are widely adopted across industries to support employee health and boost productivity. Growing demand has led to emergence of several startups expertizing in exoskeleton technology and providing solutions for rehabilitation. Furthermore, constantly evolving exoskeleton industry is driving market players to devise innovative product development strategies to boost adoption over the forecast period. For instance, in June 2022, Ekso Bionics received 510(k) FDA clearance for marketing the EksoNR robotic exoskeleton. It is the latest generation of devices that can be used for rehabilitation of multiple sclerosis patients.
Increasing prevalence of spinal cord injury is boosting the growth of exoskeleton market as the patients suffering from spinal cord injury are recommended to use exoskeleton to improve their condition. This has become major driver for adoption of exoskeleton by patients as well as healthcare providers. According to world Health Organization, every year in world around 250000 - 500000 people suffer from spinal cord surgery and this increasing number of patients is resulting in increasing use of exoskeleton.
Some of the most common musculoskeletal injuries and disorders affecting the construction industry are occupational overuse syndrome (OOS), cumulative trauma disorders (CTD), and repetitive strain injury (RSI). For instance, as per WHO data estimates published in July 2022, approximately 1.71 billion individuals across the globe have musculoskeletal disorders that include neck pain, lower back pain, fractures, amputation, rheumatoid arthritis, and osteoarthrit is. Similarly, in 2022, according to the U.S. Bureau of Labor Statistics, approximately 502,380 workers have occupation-related musculoskeletal disorders across several industries. These are some of the driving factors boosting adoption of exoskeleton solutions owing to benefits associated with exoskeleton technology, such as augmenting or assisting users’ physical activity or capability, improving users’ health & productivity, and reducing fatigue experienced by industrial workers.
Rapid technological advancements in the exoskeleton market are expected to boost the demand for exoskeletons. Increasing popularity and growing adoption of exoskeletons by companies are expected to contribute to market growth. In addition, increasing adoption of exoskeletons in manufacturing sector, logistics, automotive, and construction is leading to a rise in penetration of exoskeletons, thereby fueling the market growth. For instance, in December 2021, IKEA and BMW are using Bionic’s fifth generation Cray X, an AI-enabled, powered exoskeleton capable of lifting an additional 70 pounds, reducing the risk of repetitive stress injuries and back injuries. Such advancements are expected to boost market growth over the forecast period.
The trend of including exoskeletons in health insurance coverage is rising, making them more accessible to patients. This is particularly evident in countries such as Germany, where specific exoskeleton systems are recognized for insurance procurement. For instance, in November 2023, ReWalk Robotics Ltd. appreciated the Centers for Medicare & Medicaid Services (CMS) for officially publishing the Calendar Year 2024 Home Health Prospective Payment System Rule. This regulation, which was issued on November 1, 2023, and is set to be implemented starting from January 1, 2024, confirms the classification of exoskeletons under the Medicare brace benefit category.
Case Study Title: “Exoskeletons for Medical Rehabilitation - A Review of Recent Advances”
Source: Journal of Assistive Technology, Tandfonline, 2023
This case study examines the advancements in medical exoskeletons, specifically for patients with spinal cord injuries, stroke recovery, and other neurological conditions. It highlights the key challenges and recent technological improvements in the development of exoskeletons that aim to restore mobility and improve rehabilitation outcomes.
Technological Integration: The study emphasizes the integration of AI, robotics, and biomechanics to enhance the adaptive capabilities of exoskeletons. These technologies help to personalize therapy, allowing for a more tailored and effective rehabilitation process.
Patient Mobility: Significant progress has been made in creating lightweight exoskeletons that are easier to wear and provide natural, intuitive movement. This improves patient comfort and encourages longer usage, which is vital for rehabilitation.
Market Adoption: Despite technological advances, the study highlights that cost, regulatory hurdles, and the need for medical supervision limit wider adoption in rehabilitation centers.
Example: Ekso Bionics' EksoGT is a key example of an exoskeleton used for walking assistance in stroke and spinal injury patients. The device has shown positive results in improving patient mobility and rehabilitation.
Exoskeletons are promising tools for rehabilitation, but cost-efficiency, user comfort, and long-term effectiveness need continued refinement for broader market integration
The exoskeleton market is characterized by a high degree of innovation due to the rapid technological advancements driven by factors such as advancements in robotics and artificial intelligence technology. Novel and innovative applications of exoskeletons are constantly emerging, leading to the creation of new opportunities for market players.
Level of M&A Activities: The exoskeleton market is characterized by a high level of merger and acquisition (M&A) activity by the leading players. This is due to several factors, including the desire to access new robotic technologies needed to consolidate in a rapidly growing market and the increasing adoption of these newly developed exoskeletons.
Well-developed regulatory framework and rising approval for the exoskeleton products from these regulatory bodies positively impact market growth. The certifications and standards provided by government authorities for exoskeletons in their manufacture, deployment, and use would enhance their adoption at workplace.
Traditional rehabilitation methods remain prevalent, and exoskeletons are emerging as valuable alternatives. They offer advantages such as enhanced mobility and independence for patients with spinal cord injuries or neurological disorders. The high cost and need for specialized training may limit their widespread adoption, positioning them as complementary rather than direct substitutes to conventional therapies.
Several market players are expanding their business by entering new geographical regions to strengthen their market position and expand their product portfolio. Rising research and development activities create more opportunities for market players to enter new regions.
The mobile segment led the market in 2024 with the largest revenue share of 62.39% and is anticipated to witness fastest CAGR over the forecast period. Factors such as a rise in research and development activities and a surge in demand for motor-equipped robots aiding human body mechanics are attributed to market growth. For instance, in October 2022, a research team at Stanford University funded by NIH developed an exoskeleton that can assist with walking .
Moreover, availability of favorable reimbursement policies promoting adoption of exoskeleton technologies in emerging economies & developing nations directly contributes to the segment's development and growth.
The fixed/stationary segment is expected to grow significantly, driven by increasing demand for rehabilitation and assisted living solutions. These devices, designed to aid patients with limited mobility, provide vital support for standing, posture correction, and walking stationary. For instance , the NX A3-M is a fixed-frame exoskeleton designed for gait rehabilitation, offering improvements over the earlier NX-A3 model.
The powered segment held the largest revenue share in 2024 owing to rising implementation of powered exoskeleton solutions in several industries to enhance personal safety and boost productivity. In addition, the rise in innovative product launches and benefits associated with powered technology products are smoother lifting motion, reduced strain on worker’s body, increased strength, force multiplier, and enhanced productivity. For instance , in August 2024, Arc’teryx and Skip teamed up to introduce the world’s first powered pants, a wearable exoskeleton designed to improve human mobility by providing powered support.
Non-powered technology segment is anticipated to register the fastest growth rate over the forecast period, driven by demand for cost-effective, lightweight solutions that assist with lifting and mobility without relying on external power sources. These devices use mechanical systems, like elastics or springs, to enhance movement and reduce fatigue, making them ideal for industrial and rehabilitation applications. Key drivers include the rising need for manual labor assistance in logistics, construction, and healthcare sectors, where workers handle heavy loads. For instance, the UPLIFT exoskeleton utilizes elastic mechanisms to support lifting tasks, highlighting the growing adoption of affordable, non-powered solutions in the workforce.
By extremity, market is segmented into lower body,upper body and full body. Lower body segment dominated the market in terms of revenue share owing to rising investments, growing incidence of lower body disabilities, and increasing adoption rates of exoskeleton products by geriatric populations and paralyzed patients for weight-bearing capabilities and mobility. Initiatives such as, in April 2024, the ABLE Exoskeleton, a lightweight and affordable hip-knee-powered device by ABLE Human Motion, has received CE Mark approval under the new Medical Device Regulation, enabling its commercial sale for spinal cord injury rehabilitation in the EU.
The upper body segment is anticipated to register the fastest growth rate over the forecast period due to benefits provided by exoskeleton products in the upper extremities, such as supporting disabled communities and rehabilitation aid in post-stroke, neurological, or musculoskeletal impairments. Furthermore, growing prevalence of neurological disorders led to a rise in market growth. For instance, in May 2022, according to data published by the European Academy of Neurology, globally, a neurological disease affects 1 in 3 people at some point in their life.
Healthcare segment dominated the market in terms of revenue share in 2024, owing to the rising incidence rate of spinal cord injuries (SCIs), widespread adoption of these products & solutions in rehabilitation centers, and significant surge in treatment numbers are some of the key driving factors. Moreover, a growing number of regulatory approvals and rising awareness of technologically advanced systems are driving the demand & adoption rate of exoskeleton products in the healthcare industry. For instance, in October 2023, Wandercraft SAS launched in the U.S. commercial operations of its exoskeleton, Atalante X. The solution is used for individuals with mobility impairments.
Industry segment is anticipated to register the fastest growth over the forecast period owing to rising awareness levels towards the benefits of exoskeleton technologies in several industry applications and the rapidly growing incidence rate of occupation-related injuries. Furthermore, the surge in demand for novel technologies and growing adoption of the exoskeleton in multiple sectors such as construction, manufacturing, and distribution is expected to accelerate growth of the industry segment.
North America led the market in 2024, capturing 45.13% of the revenue and 26.32% of the volume share, driven by increasing investment in research, a growing disabled population, and expanding partnerships among key players, availability of advanced technologies, and strong public and private sector support. For instance, in March 2021, Ekso Bionics, an exoskeleton technology company, partnered with U.S. Physiatry (USP) to educate clinicians or physicians on the clinical benefits of an EksoNR exoskeleton. Moreover, rising disposable income, a rapidly growing geriatric population, widespread presence of key market players, growing human augmentation in industry and military verticals, and availability of public & private investors are driving the growth.
The U.S. dominated the North America exoskeleton market due to its strong focus on technological innovation, high investment in healthcare and military sectors, and the widespread presence of leading exoskeleton manufacturers. For instance, in April 2025, Lifeward Ltd. announced the nationwide U.S. launch of the ReWalk 7 Personal Exoskeleton, representing the latest advancement in its technology.
“The ReWalk 7 was developed over several years, integrating advanced technological innovations with feedback from clinicians and patients to build upon the ReWalk’s world-class reputation for industry leadership. The result is a device that is optimized for real-world use, with an unmatched user experience and freedom of movement. We are thrilled to be able to provide paralyzed individuals across the country with a new option for integrating walking to everyday life.”
- Larry Jasinski, CEO of Lifeward
Asia Pacific is anticipated to register the fastest growth rate during the forecast period owing to a growing patient pool requiring rehabilitation support. Availability of government support & funding and developing & advancing healthcare infrastructure are driving the development & growth of the exoskeleton market in Asia Pacific. Constant economic development in economies such as China, Japan, and India, coupled with favorable public & private support, is expected to bolster the development & growth.
The exoskeleton market in China is rapidly advancing in technologies, focusing on enhancing mobility and strength. Chinese engineers are actively working on creating exoskeleton suits to assist astronauts, demonstrating the country's commitment to innovation in this field. In addition, in January 2025, the Chinese military showcased exoskeletons for logistics operations.
Strong regulatory frameworks and a focus on medical and industrial applications drive the exoskeleton market in Europe. The European Medicines Agency (EMA) ensures that medical exoskeletons meet stringent safety and efficacy standards, facilitating their integration into healthcare systems. Countries such as Germany, France, and the UK are leading in adopting these technologies for rehabilitation and industrial use.
The Germany exoskeleton market is growing in terms of technologies, and the country benefits from a well-established regulatory framework that supports the development and deployment of exoskeletons. The European Medicines Agency (EMA) is vital in ensuring the safety and effectiveness of medical exoskeletons, helping them integrate into healthcare systems.
The exoskeleton market in Latin America is growing significantly. In November 2024, Einstein Hospital in São Paulo is conducting clinical trials to assess the effectiveness of exoskeletons in rehabilitation. It will be the first hospital in Latin America to use an exoskeleton that senses the patient’s movement intentions, amplifies the neurological micro-signals, and aids in executing the movement. This innovation enables patients to play a more active role in their rehabilitation.
Brazil exoskeleton market held largest share in Latin America in 2024. is facilitating innovation in exoskeleton technology through local initiatives. Startups, including Exy Innovation, are developing wearable exoskeletons tailored to the Brazilian workforce to enhance productivity and reduce workplace injuries. In addition, research institutions are collaborating to create cost-effective and adaptable solutions suitable for tropical environments, addressing the region's unique needs.
The exoskeleton market in the Middle East and Africa (MEA) region is experiencing rapid growth. Countries such as Saudi Arabia, the UAE, and South Africa are investing in healthcare infrastructure, including rehabilitation centers equipped with exoskeleton technologies. Public and private sector investments support this expansion to enhance mobility solutions for individuals with disabilities.
The exoskeleton market in South Africa is witnessing advancements, focusing on enhancing mobility and strength. Local initiatives are developing wearable exoskeletons tailored to the South African workforce to improve productivity and reduce workplace injuries. In addition, research institutions collaborate to create cost-effective and adaptable solutions suitable for the region's unique needs.
Key players who focus on innovation, product development, and strategic partnerships to maintain their market positions dominate the exoskeleton market. For instance[VB17] , in March 2023, Svaya Robotics developed quadruped robot and a wearable exoskeleton. The exoskeleton is specially designed to match the body structure of Indian soldiers, enhancing their physical strength to help them walk long distances without fatigue and carry heavy loads with reduced effort. The market share is concentrated among established players with extensive resources for research and development, while emerging players focus on cost-effective solutions and technological advancements.
The following are the leading companies in the exoskeleton market. These companies collectively hold the largest market share and dictate industry trends.
“I wanted to create a wheelchair that could walk. An ordinary wheelchair can only move on a regular path, but it cannot get on the bus or go up and down the stairs. So my view is that if a wheelchair could be folded up and help the person sitting in it to get up and walk, it would make it easier for people with reduced mobility to walk.”
- Assoc. Prof. Dr. Ronnapee Chaichawarat, a professor from the International School of Engineering (ISE), Chulalongkorn University
“The launch of this trial is a major milestone in our journey to redefine what mobility technology can achieve. We’ve seen the profound impact of our exoskeletons in rehabilitation centers, and now we are thrilled to explore how the Personal Exoskeleton could represent a significant leap forward in mobility and walking independence for people with severe walking impairment, starting with SCI, enabling them to walk hands-free without relying on crutches or walkers."
- Matthieu Masselin, CEO of Wandercraft
“We know from extensive experience in both industrial and healthcare settings that there are moments in a worker’s day when tasks demand an extra level of strength - whether it’s lifting a particularly heavy package or mobilizing an incapacitated patient. That’s exactly why we created the Ultra-Mode, giving users that powerful boost they need to complete these challenging tasks more safely and with greater ease.”
- Norma Steller, Head of Development at German Bionic
In December 2024, RoboCT's UGO Series Rehab Exoskeleton received CE certification, officially recognizing it as a medical device.
In November 2024, Hippos Exoskeleton will release a knee brace featuring airbags designed to help prevent ACL injuries.
“The core technology we invented is not only on the hardware side, but also on the software side: the AI, the data processing capability and the ability to use our AI model, which we designed by ourselves, to personalize the triggering threshold for every single individual, athletes, soldiers, patients.”
- Kylin Shaw, Hippos CEO
In December 2022, Ekso Bionics announced the acquisition of Parker Hannifin Corporation’s Human Motion and Control business unit. This acquisition includes Parker’s Indego lower limb exoskeleton product line and the strategic development of robot-assisted prosthetic and orthotic devices.
In June 2022, CYBERDYNE Inc. formed a business and capital alliance with LIFESCAPES Inc. This collaboration highlighted the combined effort to further leverage the exoskeleton technology arena and improve rehabilitation options for patients with severe paralysis.
In June 2022, CYBERDYNE Inc. announced its collaboration with the Social Security Organization (SOCSO) in Malaysia. This initiative led to the expansion of Cybernics Treatment using hybrid assistive limb (HAL) for SOCSO-insured patients.
Report Attribute |
Details |
Market size value in 2025 |
USD 590.02 million |
Revenue forecast in 2030 |
USD 1.25 billion |
Growth rate |
CAGR of 16.27% from 2025 to 2030 |
Actual data |
2018 - 2024 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
Report coverage |
Revenue & volume forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Mobility, technology, extremity, end use , region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Mexico; Germany; UK; Spain; Italy; France; Denmark; Norway; Sweden; Japan; China; India; Australia; Thailand; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Ekso Bionics; ARMASTEC PTE. LTD; Hocoma; Lockheed Martin Corporation; Suit X; Rex Bionics Plc.; RB3D; ReWalk Robotics; Cyberdyne, Inc.; ActiveLink (Panasonic Corporation); DIH Medical |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue and volume growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2018 to 2030. For the purpose of this study, Grand View Research, Inc. has segmented the global exoskeleton market report on the basis of mobility, technology, extremity, end use, and region:
Mobility Outlook (Revenue, USD Million, 000' Units, 2018 - 2030)
Mobile
Fixed/Stationary
Technology Outlook (Revenue USD Million, 000’ Units, 2018 - 2030)
Powered
Non-powered
Extremity Outlook (Revenue USD Million, 000’ Units, 2018 - 2030)
Upper Body
Lower Body
Full Body
End Use Outlook (Revenue USD Million, 000’ Units, 2018 - 2030)
Healthcare
Military
Industry
Regional Outlook Revenue USD Million, 000’ Units, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
Spain
Italy
France
Denmark
Norway
Sweden
Rest of Europe
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
MEA
South Africa
Saudi Arabia
UAE
Kuwait
Rest of MEA
b. The global exoskeleton market size was valued at USD 498.33 million in 2024 and is expected to reach USD 590.02 million in 2025.
b. The global exoskeleton market is expected to grow at a compound annual growth rate of 16.27% from 2025 to 2030 to reach USD 1.25 billion by 2030.
b. Mobile segment dominated the exoskeleton market with a revenue share of 62.39% in 2024. This is attributable to the introduction of innovative mobile exoskeletons by manufacturers for the aging and disabled population.
b. Some key players operating in the exoskeleton market include Rex Bionics Plc.; Hocoma; Lockheed Martin Corporation; Suit X; ReWalk Robotics; RB3D; ReWalk Robotics Ltd; Cyberdyne, Inc.; and ActiveLink (Panasonic Corporation).
b. Key factors that are driving the exoskeleton market growth include the growing adoption of exoskeletons in healthcare and non-healthcare settings, technological advancements, and the increasing prevalence of spinal cord injuries (SCIs).
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Mobility
1.2.2. Technology
1.2.3. Extremity
1.2.4. Structure
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Mobility outlook
2.2.2. Technology outlook
2.2.3. Extremity outlook
2.2.4. Structure outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Exoskeleton Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidence of spinal cord injury
3.2.1.2. Increasing incidence of musculoskeletal disorders
3.2.1.3. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High procedural costs
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Exoskeleton Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
3.4. Key Trends in the Exoskeleton/Exo Robots Market
3.5. Key Developments in the Exoskeleton/Exo Robots Market
3.6. Patent Analysis
3.7. Patent Disputer
3.8. Case Studies & Insights
3.9. Supply Chain Analysis for Exoskeletons
3.10. Current Regulatory Analysis
3.11. Ecosystem Analysis
3.12. Pricing Analysis
3.13. Upcoming Innovations in the Market
Chapter 4. Exoskeleton Market: Mobility Estimates & Trend Analysis
4.1. Global Exoskeleton Market: Mobility Dashboard
4.2. Mobility Market Share Analysis, 2024 & 2030
4.3. Exoskeleton Market: By Mobility, 2018 to 2030
4.4. Mobile
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
4.5. Fixed/Stationary
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
Chapter 5. Exoskeleton Market: Technology Estimates & Trend Analysis
5.1. Global Exoskeleton Market: Technology Dashboard
5.2. Technology Market Share Analysis, 2024 & 2030
5.3. Exoskeleton Market: By Technology, 2018 to 2030
5.4. Powered
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
5.4.2. Powered by Extremity
5.4.2.1. Upper
5.4.2.1.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
5.4.2.2. Lower
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
5.4.2.3. Full
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
5.5. Non-Powered
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
5.5.2. Non-Powered by Extremity
5.5.2.1. Upper
5.5.2.1.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
5.5.2.2. Lower
5.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
5.5.2.3. Full
5.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
Chapter 6. Exoskeleton Market: Extremity Estimates & Trend Analysis
6.1. Global Exoskeleton Market: Extremity Dashboard
6.2. Extremity Market Share Analysis, 2024 & 2030
6.3. Exoskeleton Market: By Extremity, 2018 to 2030
6.4. Upper Body
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
6.5. Lower Body
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
6.6. Full Body
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
Chapter 7. Exoskeleton Market: Structure Estimates & Trend Analysis
7.1. Global Exoskeleton Market: Structure Dashboard
7.2. Structure Market Share Analysis, 2024 & 2030
7.3. Exoskeleton Market: By Structure, 2018 to 2030
7.4. Rigid Exoskeletons
7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
7.5. Soft Exoskeletons
7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
Chapter 8. Exoskeleton Market: End Use Estimates & Trend Analysis
8.1. Global Exoskeleton Market: End Use Dashboard
8.2. End Use Market Share Analysis, 2024 & 2030
8.3. Exoskeleton Market: By End Use, 2018 to 2030
8.4. Healthcare
8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
8.5. Military
8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
8.6. Industry
8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million, 000’ Units)
Chapter 9. Exoskeleton Market: Regional Estimates & Trend Analysis by component, application and end use
9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Dashboard
9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. U.S.
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework
9.4.1.3. Competitive scenario
9.4.1.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.4.1.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.4.2. Canada
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Competitive scenario
9.4.2.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.4.3. Mexico
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Competitive scenario
9.4.3.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.5. Europe
9.5.1. UK
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework
9.5.1.3. Competitive scenario
9.5.1.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.5.1.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.5.2. Germany
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Competitive scenario
9.5.2.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.5.3. France
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Competitive scenario
9.5.3.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.5.4. Italy
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Competitive scenario
9.5.4.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.5.5. Spain
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework
9.5.5.3. Competitive scenario
9.5.5.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.5.5.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.5.6. Denmark
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework
9.5.6.3. Competitive scenario
9.5.6.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.5.6.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.5.7. Sweden
9.5.7.1. Key country dynamics
9.5.7.2. Regulatory framework
9.5.7.3. Competitive scenario
9.5.7.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.5.7.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.5.8. Norway
9.5.8.1. Key country dynamics
9.5.8.2. Regulatory framework
9.5.8.3. Competitive scenario
9.5.8.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.5.8.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.5.9. Rest of Europe
9.5.9.1. Key country dynamics
9.5.9.2. Regulatory framework
9.5.9.3. Competitive scenario
9.5.9.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.5.9.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.6. Asia Pacific
9.6.1. Japan
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework
9.6.1.3. Competitive scenario
9.6.1.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.6.1.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.6.2. China
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework
9.6.2.3. Competitive scenario
9.6.2.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.6.3. India
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework
9.6.3.3. Competitive scenario
9.6.3.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.6.4. South Korea
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework
9.6.4.3. Competitive scenario
9.6.4.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.6.5. Thailand
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework
9.6.5.3. Competitive scenario
9.6.5.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.6.6. Australia
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework
9.6.6.3. Competitive scenario
9.6.6.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.6.7. Rest of Asia Pacific
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework
9.6.7.3. Competitive scenario
9.6.7.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.7. Latin America
9.7.1. Brazil
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework
9.7.1.3. Competitive scenario
9.7.1.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.7.1.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.7.2. Argentina
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework
9.7.2.3. Competitive scenario
9.7.2.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.7.3. Rest of Latin America
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework
9.7.3.3. Competitive scenario
9.7.3.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.8. MEA
9.8.1. South Africa
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework
9.8.1.3. Competitive scenario
9.8.1.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.8.1.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.8.2. Saudi Arabia
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework
9.8.2.3. Competitive scenario
9.8.2.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.8.3. UAE
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework
9.8.3.3. Competitive scenario
9.8.3.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.8.4. Kuwait
9.8.4.1. Key country dynamics
9.8.4.2. Regulatory framework
9.8.4.3. Competitive scenario
9.8.4.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.8.4.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
9.8.5. Rest of MEA
9.8.5.1. Key country dynamics
9.8.5.2. Regulatory framework
9.8.5.3. Competitive scenario
9.8.5.4. Market estimates and forecasts 2018 to 2030 (USD Million)
9.8.5.5. Market volume estimates and forecasts 2018 to 2030 (000’ Units)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Exoskeleton/Exo Robots Key Market Performance Indicators
10.4. Company Profiles
10.4.1. Ekso Bionics
10.4.1.1. Overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. ARMASTEC PTE. LTD.
10.4.2.1. Overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Hocoma
10.4.3.1. Overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Lockheed Martin Corporation
10.4.4.1. Overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Suit X
10.4.5.1. Overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Rex Bionics Plc.
10.4.6.1. Overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. RB3D
10.4.7.1. Overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. ReWalk Robotics
10.4.8.1. Overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Cyberdyne, Inc.
10.4.9.1. Overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. ActiveLink (Panasonic Corporation)
10.4.10.1. Overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
10.4.11. DIH Medical
10.4.11.1. Overview
10.4.11.2. Financial performance
10.4.11.3. Product benchmarking
10.4.11.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 4 North America exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 5 North America exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 6 North America exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 7 North America exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 8 North America exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 9 North America exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 10 North America exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 11 U.S. exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 12 U.S. exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 13 U.S. exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 14 U.S. exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 15 U.S. exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 16 U.S. exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 17 U.S. exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 18 U.S. exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 19 Canada exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 20 Canada exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 21 Canada exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 22 Canada exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 23 Canada exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 24 Canada exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 25 Canada exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 26 Canada exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 27 Mexico exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 28 Mexico exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 29 Mexico exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 30 Mexico exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 31 Mexico exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 32 Mexico exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 33 Mexico exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 34 Mexico exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 35 Europe exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 36 Europe exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 37 Europe exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 38 Europe exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 39 Europe exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 40 Europe exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 41 Europe exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 42 Europe exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 43 Germany exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 44 Germany exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 45 Germany exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 46 Germany exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 47 Germany exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 48 Germany exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 49 Germany exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 50 Germany exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 51 UK exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 52 UK exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 53 UK exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 54 UK exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 55 UK exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 56 UK exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 57 UK exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 58 UK exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 59 Spain exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 60 Spain exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 61 Spain exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 62 Spain exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 63 Spain exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 64 Spain exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 65 Spain exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 66 Spain exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 67 Italy exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 68 Italy exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 69 Italy exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 70 Italy exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 71 Italy exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 72 Italy exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 73 Italy exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 74 Italy exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 75 France exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 76 France exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 77 France exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 78 France exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 79 France exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 80 France exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 81 France exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 82 France exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 83 Denmark exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 84 Denmark exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 85 Denmark exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 86 Denmark exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 87 Denmark exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 88 Denmark exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 89 Denmark exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 90 Denmark exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 91 Norway exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 92 Norway exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 93 Norway exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 94 Norway exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 95 Norway exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 96 Norway exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 97 Norway exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 98 Norway exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 99 Sweden exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 100 Rest of Europe exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 101 Rest of Europe exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 102 Rest of Europe exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 103 Asia Pacific exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 104 Asia Pacific exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 105 Asia Pacific exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 106 Asia Pacific exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 107 Asia Pacific exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 108 Asia Pacific exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 109 Asia Pacific exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 110 Asia Pacific exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 111 Japan exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 112 Japan exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 113 Japan exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 114 Japan exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 115 Japan exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 116 Japan exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 117 Japan exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 118 Japan exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 119 China exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 120 China exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 121 China exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 122 China exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 123 China exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 124 China exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 125 China exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 126 China exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 127 India exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 128 India exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 129 India exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 130 India exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 131 India exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 132 India exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 133 India exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 134 India exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 135 Australia exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 136 Australia exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 137 Australia exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 138 Australia exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 139 Australia exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 140 Australia exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 141 Australia exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 142 Australia exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 143 Thailand exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 144 Thailand exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 145 Thailand exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 146 Thailand exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 147 Thailand exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 148 Thailand exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 149 Thailand exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 150 Thailand exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 151 South Korea exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 152 South Korea exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 153 South Korea exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 154 South Korea exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 155 South Korea exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 156 South Korea exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 157 South Korea exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 158 South Korea exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 159 Rest of Asia Pacific exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 160 Rest of Asia Pacific exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 161 Rest of Asia Pacific exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 162 Rest of Asia Pacific exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 163 Rest of Asia Pacific exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 164 Rest of Asia Pacific exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 165 Rest of Asia Pacific exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 166 Rest of Asia Pacific exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 167 Latin America exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 168 Latin America exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 169 Latin America exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 170 Latin America exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 171 Latin America exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 172 Latin America exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 173 Latin America exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 174 Latin America exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 175 Brazil exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 176 Brazil exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 177 Brazil exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 178 Brazil exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 179 Brazil exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 180 Brazil exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 181 Brazil exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 182 Brazil exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 183 Argentina exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 184 Argentina exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 185 Argentina exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 186 Argentina exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 187 Argentina exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 188 Argentina exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 189 Argentina exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 190 Argentina exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 000’ Units)
Table 191 Rest of Latin America exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 192 Rest of Latin America exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume, 000’ Units)
Table 193 Rest of Latin America exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 194 Rest of Latin America exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume, 000’ Units)
Table 195 Rest of Latin America exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 196 Rest of Latin America exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume, 000’ Units)
Table 197 Rest of Latin America exoskeleton market estimates and forecasts, by end use, 2018 (USD Million)
Table 198 Rest of Latin America exoskeleton market estimates and forecasts, by end use, 2018 (Volume, 000’ Units)
Table 199 Rest of MEA exoskeleton market estimates and forecasts, by mobility, 2018 - 2030 (USD Million)
Table 200 Rest of MEA exoskeleton market volume estimates and forecasts, by mobility, 2018 - 2030 (Volume,
Table 201 Rest of MEA exoskeleton market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 202 Rest of MEA exoskeleton market volume estimates and forecasts, by technology, 2018 - 2030 (Volume
Table 203 Rest of MEA exoskeleton market estimates and forecasts, by extremity, 2018 - 2030 (USD Million)
Table 204 Rest of MEA exoskeleton market volume estimates and forecasts, by extremity, 2018 - 2030 (Volume,
Table 205 Rest of MEA exoskeleton market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Table 206 Rest of MEA exoskeleton market volume estimates and forecasts, by end use, 2018 - 2030 (Volume, 0
Table 207 South Africa exoskeleton market estimates and forecasts, 2018 - 2030 (USD Million)
Table 208 South Africa exoskeleton market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Table 209 Saudi Arabia exoskeleton market estimates and forecasts, 2018 - 2030 (USD Million)
Table 210 Saudi Arabia exoskeleton market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Table 211 UAE exoskeleton market estimates and forecasts, 2018 - 2030 (USD Million)
Table 212 UAE exoskeleton market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Table 213 Kuwait exoskeleton market estimates and forecasts, 2018 - 2030 (USD Million)
Table 214 Kuwait exoskeleton market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market research approaches
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Exoskeleton market: market outlook
Fig. 7 Exoskeleton competitive insights
Fig. 8 Parent market outlook
Fig. 9 Related/ancillary market outlook
Fig. 10 Exoskeleton market driver impact
Fig. 11 Exoskeleton market restraint impact
Fig. 12 Exoskeleton market: Mobility movement analysis
Fig. 13 Exoskeleton market: Mobility outlook and key takeaways
Fig. 14 Mobile market estimates and forecast, 2018 - 2030 (USD Million, 000’ Units)
Fig. 15 Fixed/stationary market estimates and forecast, 2018 - 2030 (USD Million, 000’ Units)
Fig. 16 Exoskeleton market: Technology movement analysis
Fig. 17 Exoskeleton market: Technology outlook and key takeaways
Fig. 18 Powered market estimates and forecast, 2018 - 2030 (USD Million, 000’ Units)
Fig. 19 Non-powered market estimates and forecast, 2018 - 2030 (USD Million, 000’ Units)
Fig. 20 Exoskeleton market: Extremity movement analysis
Fig. 21 Exoskeleton market: Extremity outlook and key takeaways
Fig. 22 Upper body market estimates and forecast, 2018 - 2030 (USD Million, 000’ Units)
Fig. 23 Lower body market estimates and forecast, 2018 - 2030 (USD Million, 000’ Units)
Fig. 24 Full body market estimates and forecast, 2018 - 2030 (USD Million, 000’ Units)
Fig. 25 Exoskeleton market: End Use movement analysis
Fig. 26 Exoskeleton market: End Use outlook and key takeaways
Fig. 27 Healthcare market estimates and forecast, 2018 - 2030 (USD Million, 000’ Units)
Fig. 28 Military market estimates and forecast, 2018 - 2030 (USD Million, 000’ Units)
Fig. 29 Industry market estimates and forecast, 2018 - 2030 (USD Million, 000’ Units)
Fig. 30 Global Exoskeleton market: Regional movement analysis
Fig. 31 Global Exoskeleton market: Regional outlook and key takeaways
Fig. 32 Global Exoskeleton market share and leading players
Fig. 33 North America, by country
Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 North America market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 36 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Canada market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 40 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Mexico market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 42 Europe, by country
Fig. 43 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Europe market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 UK market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Germany market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 France market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Italy market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Spain market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Denmark market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 57 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Sweden market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Norway market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 61 Asia Pacific, by country
Fig. 62 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Asia Pacific market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 64 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 China market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 66 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Japan market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 68 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 India market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 70 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Thailand market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 72 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 South Korea market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 74 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Australia market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 76 Latin America, by country
Fig. 77 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Latin America market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 79 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Brazil market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 81 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Argentina market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 83 Middle East and Africa, by country
Fig. 84 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Middle East and Africa market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 86 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 South Africa market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 88 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Saudi Arabia market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 90 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 UAE market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Fig. 92 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Kuwait market volume estimates and forecasts, 2018 - 2030 (Volume, 000’ Units)
Market Segmentation
Report content
Qualitative Analysis
Quantitative Analysis
Research Methodology
Grand View Research employs a comprehensive and iterative research methodology focused on minimizing deviance to provide the most accurate estimates and forecasts possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation which looks market from three different perspectives. Critical elements of the methodology employed for all our studies include:
Preliminary data mining
Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For a comprehensive understanding of the market, it is essential to understand the complete value chain, and to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.
Technical issues and trends are obtained from surveys, technical symposia, and trade journals. Technical data is also gathered from an intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, and pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.
Statistical model
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression, and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, industry experience, and domain expertise.
Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of the technology landscape, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:
• Market drivers and restraints, along with their current and expected impact
• Raw material scenario and supply v/s price trends
• Regulatory scenario and expected developments
• Current capacity and expected capacity additions up to 2030
We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.
Primary validation
This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, on face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts, and buyers to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation but also provide critical insights into the market, current business scenario, and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:
• Market-leading companies
• Raw material suppliers
• Product distributors
• Buyers
The key objectives of primary research are as follows:
• To validate our data in terms of accuracy and acceptability
• To gain an insight into the current market and future expectations
Data Collection Matrix
Perspective |
Primary research |
Secondary research |
Supply-side |
|
|
Demand-side |
|
|
Industry Analysis Matrix
Qualitative analysis |
Quantitative analysis |
|
|
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."